Polymorphisms involved in folate metabolism pathways and the risk of the development of childhood acute leukemia

Genetic Testing and Molecular Biomarkers

Volumn 17, Issue 2, 2013, Pages 147-152

  Silva, Rafaela Maria Seabra ^a,b   Fontes, Alide Caroline Lima ^b,c   Silva, Karina Alves ^b   Sant'Ana, Thalita Araújo ^b,c   Ramos, Flávio José Da Costa ^b   Marques Salles, Terezinha De Jesus ^b   Pombo De Oliveira, Maria S ^d   Muniz, Maria Tereza Cartaxo ^a,b,c  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b Hospital Universitario Oswaldo Cruz   (Brazil)

^c FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^d INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BRAZIL; CANCER GROWTH; CANCER RISK; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; FOLATE METABOLISM; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; METHYLENETETRAHYDROFOLATE REDUCTASE GENE; POLYMERASE CHAIN REACTION; REDUCED FOLATE CARRIER GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; THYMIDYLATE SYNTHASE GENE;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; FOLIC ACID; GENOTYPE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; REPLICATION PROTEIN C; RISK; THYMIDYLATE SYNTHASE; YOUNG ADULT;

EID: 84872863550     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2012.0174     Document Type: Article

References (34)

1. Assaraf YG. Molecular basis of antifolate resistance. (2007) Cancer Metastasis Rev 26:153-181.
2. Chango A, Emery-Fillon N, De Courcy GP, et al. (2000) A polymorphism (80G→A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia. Molec Genetics and Metab 70:310-315.
3. De Jonge R, Tissing WJE, Hooijberg JH, et al. (2009) Polymorphisms in folate-related genes and risk of pediatric acute lymphoblastic leukemia. Blood113:2284-2289.
4. De Souza Reis R Sr, de Camargo B, de Oliveira Santos M, et al. (2011) Childhood leukemia incidence in Brazil according to different geographical regions. Pediatric Blood Cancer 56:58-64.
5. Franco RF, Simoes BP, Tone LG, et al. (2001) The methylenete- trahydrofolate reductase C677T gene polymorphism decreases the risk of childhood acute lymphocytic leucemia. Br J Hae-matol 115:616-618.
6. Frosst P, Blom HJ, Milos R, et al. (1995) A candidate genetic risk fator for vascular disease: a common mutation in methylene-tetrahydrofolat reductase. Nat Genet 10:111-113.
7. Gast A, Bermejo JL, Flohr T, et al. (2007) Folate metabolic gene polymorphisms and childhood acute lymphoblastic leukemia: a case-control study. Leukemia 21:320-325.
8. Gemmati D, Ongaro A, Scapoli GL, et al. (2004) Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults. Cancer Epidemiol Bio-markers Prev 13:787-794.
9. Hishida A, Matsuo K, Hamajima N, et al. (2003) Associations between polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and susceptibility to malignant lymphoma. Haematologica 88:159-166.
10. Homberger A, Linnebank M, Winter C, et al. Genomic structure and transcript variants of the human methylenete-trahydrofolate reductase gene. (2000) Eur J Hum Genet 8: 725-729.
11. Kamel AM, Moussa HS, Ebid GT, et al. (2007). Synergistic effect of methyltetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphism as risk modifiers of pediatric acute lymphoblastic leukemia. J Egyptian Nat Cancer Inst 19:96-105.
12. Kamel AM, Moussa HS, Ebid GT, et al. (2009) Synergistic effect of methyltetrahydrofolate reductase (MTHFR) C677T and A1280C polymorphism as risk modifiers of pediatric acute lymphoblastic leukemia. J Egyptian Nat Cancer Inst 19:96-105.
13. Kawakami K, Omura K, Kanehira E, et al. (1999) Polymorphic tandem repeats in the thymidylate synthase gene is associated with its protein expression in human gastrointestinal cancers. Anticancer Res 19:3249-3252.
14. Kim HN, Kim YK, Lee IK, et al. (2009) Association between polymorphism of folate metabolizing enzymes and hemato-logical malignances. Leukemia Res 33:82-87.
15. Krajinovic M, Lamoethe S, Labuda D, et al. (2009) Role of MTHFR genetic polymorphisms in the susceptibility to childhoodacute lymphoblastic leukemia. Blood 113:252-257.
16. Lightfoot TJ, Skibola CF, Willett EV, et al. (2005) Risk of non-Hodgkin lymphoma associated with polymorphisms in folate-metabolizing genes. Cancer Epidemiol Biomarkers Prev 14: 2999-3003.
17. Lucock M (2000) Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab 71: 121-138.
18. Marsh S, Ameyaw MM, Githan'a J, et al. (2000) Novel thymi-dylate synthase enhancer region alleles in African population. Hum Mutat 20:174-179.
19. Marsh S, McKay JA, Casidy J, et al. (2001) Polymorphism in the thymidylate synthase prometor enhancer region in colorectal cancer. Int J Oncol 19:383-386.
20. Parra FC, Amado RC, Lambertucci JR, et al. (2003) Color and genomic ancestry in Brazilians. PNAS USA 100:177-182.
21. Pereira AC, Schettert IT, Morandini Filho AA, et al. (2004) Methylenetetrahydrofolate reductase (MTHFR) C677T gene variant modulates the homocysteine folate correlation in a mild folate deficiente population. Clin Chim Acta 340: 99-105.
22. Pereira TV, Rudnicki M, Pereira AC, et al. (2006) 5, 10-Methyle- netetrahydrofolate reductase polymorphisms and acute lym-phoblastic leukemia risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15:1956-1963.
23. Ranjith N, Pegoraro RJ, Rom L (2003) Risk factors and methylenetetrahydrofolate reductase gene polymorphisms in a young South African Indianbased population with acute myocardial infarction. Cardiovasc J South Afr 14:127-132.
24. Relton CL, Wilding CS, Laffling AJ, et al. (2004) Lowerythrocyte folate status and polymorphic variation in folate-related genes are associated with risk of neural tube defect pregnancy. Mol Genet Metab 81:273-281.
25. Rosenblatt DS (2001) Clinically important genes: methylenete- trahydrofolate reductase. Clin Invest Med 24:56-59.
26. Skibola C, Smith T, Hubbard A, et al. (2002) Polymorphisms in the thymidylate synthase and serine hydroxymethyltrans-ferase genes and risk of adult acute lymphocytic leukemia. Blood 99:3786-3791.
27. Skibola CF, Smith MT, Kane E, et al. (1999) Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA 96:12810-12815.
28. Stiller CA, Parkin DM (1996) Geographic and ethnic variations in the incidence of childhood cancer. Br Med Bull 52:682-703.
29. Ulrich CM, Curtin K, Potter JD (2005) Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase and risk of colon cancer. Cancer Epidemiol Bio-markers Prev 14:2509-2251.
30. Vanesse GJ, Concannon P, Willerford DM (1999) Regulated genomicinstability and neoplasia in the lymphoid lineage. Blood 94:3997-4010.
31. Weisberg I, Tran P, Christensen B, et al. (1998) A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64:169-172.
32. Yates Z, Lucock M (2005) G80A reduced folate carrier SNP modulates cellular uptake of folate and affords protection against thrombosis via a non homocysteine related mechanism. Life Sci 77:2735-2742.
33. Zeller B, Gustafsson G, Forestier E, et al. (2005) Acute leukaemia in children with Down syndrome: a population-based Nordic study. Br J Haematol 128:797-804.
34. Zingg JM, Jones PA (1997) Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis. Carcinogenesis 18:869-882.